Using Pharmacogenomics to Treat Depression
hosted byConnect Educate Impact (CEI)Using Pharmacogenomics to Treat Depression is organized by Connect Educate Impact (CEI).
Initial Release Date: April 12, 2023
Planned Expiration Date: April 12, 2026
Description:
The PRIME Care Trial shows benefits of using pharmacogenomics to treat mental health conditions. Take this course to learn how using this information can gain better outcomes in treating depression.
Upon successful completion of this application-based course, participants should be able to:
• Describe how pharmacogenomics (PGx) testing can impact medications related to depression
• Recognize the impact of a multigene PGx panel on remission and response rates in patients with depression.
• Describe how PGx testing impacts rates of drug-gene interactions
• Discuss the strengths, limitations, and results of the PRIME Care Trial
• Develop a conclusion for the role of pharmacogenomics in patient-centered depression care based on a clinical trial.
Additional details will be posted as soon as information is available.
